硫酸镁联合拉贝洛尔在早发型重度子痫前期治疗与干预效果分析

Magnesium Sulfate labetalol analysis in early onset severe pre eclampsia and intervention treatment

目的 探讨分析硫酸镁联合拉贝洛尔在早发型重度子痫前期治疗与干预效果。方法 随机选取2015年-2017年患有早发型重度子痫前期治疗的患者40例作为本次的研究对象,所有患者均采用硫酸镁药物联合拉贝洛尔药物进行治疗,对治疗过程中的患者进行护理,并对护理结果进行总结。结果 患者的血压得到了平稳地控制,40例患者均未发生子痫,且未出现死亡的现象。且37例新生儿得到了较高的Apgar评分。结论 在硫酸镁联合拉贝洛尔对早发型重度子痫前期进行治疗的基础上,应用护理干预,能够对患者的血压有效地控制,且有效地缓解病情。

Objective To investigate the analysis of Magnesium Sulfate labetalol in the treatment of early onset severe preeclampsia and intervention. Methods Randomly selected from 2015 to 2017 years with early onset of severe preeclampsia patients 40 cases as the object of this study, all patients were treated with labetalol and Magnesium Sulfate drug drug treatment, the treatment process of nursing the patients and the nursing results were summarized. Results The blood pressure of the patients were smoothly control, 40 patients were eclampsia, and did not appear the phenomenon of death. And 37 cases of neonatal had a higher Apgar score. Conclusion In Magnesium Sulfate labetalol on early onset severe preeclampsia were treated on the application of nursing intervention, can effectively control the blood pressure of patients, and effectively alleviate the condition.